Open Access. Powered by Scholars. Published by Universities.®
- Keyword
Articles 1 - 7 of 7
Full-Text Articles in Environmental Public Health
Science And Policy On Endocrine Disrupters Must Not Be Mixed: A Reply To A “Common Sense” Intervention By Toxicology Journal Editors, Åke Bergman, Anna-Maria Andersson, Georg Becher, Martin Van Den Berg, Bruce Blumberg, Poul Bjerregaard, Carl-Gustaf Bornehag, Riana Bornman, Ingvar Brandt, Jayne V. Brian, Stephanie C. Casey, Paul A. Fowler, Heloise Frouin, Linda C. Giudice, Taisen Iguchi, Ulla Hass, Susan Jobling, Anders Juul, Karen A. Kidd, Andreas Kortenkamp, Monica Lind, Olwenn V. Martin, Derek Muir, Roseline Ochieng, Nicolas Olea, Leif Norrgren, Erik Ropstad, Peter S. Ross, Christina Rudén, Martin Scheringer, Niels Erik Skakkebaek, Olle Söder, Carlos Sonnenschein, Ana Soto, Shanna Swan, Jorma Toppari, Charles R. Tyler, Laura Vandenberg, Anne Marie Vinggaard, Karin Wiberg, R Thomas Zoeller
Science And Policy On Endocrine Disrupters Must Not Be Mixed: A Reply To A “Common Sense” Intervention By Toxicology Journal Editors, Åke Bergman, Anna-Maria Andersson, Georg Becher, Martin Van Den Berg, Bruce Blumberg, Poul Bjerregaard, Carl-Gustaf Bornehag, Riana Bornman, Ingvar Brandt, Jayne V. Brian, Stephanie C. Casey, Paul A. Fowler, Heloise Frouin, Linda C. Giudice, Taisen Iguchi, Ulla Hass, Susan Jobling, Anders Juul, Karen A. Kidd, Andreas Kortenkamp, Monica Lind, Olwenn V. Martin, Derek Muir, Roseline Ochieng, Nicolas Olea, Leif Norrgren, Erik Ropstad, Peter S. Ross, Christina Rudén, Martin Scheringer, Niels Erik Skakkebaek, Olle Söder, Carlos Sonnenschein, Ana Soto, Shanna Swan, Jorma Toppari, Charles R. Tyler, Laura Vandenberg, Anne Marie Vinggaard, Karin Wiberg, R Thomas Zoeller
Laura Vandenberg
The “common sense” intervention by toxicology journal editors regarding proposed European Union endocrine disrupter regulations ignores scientific evidence and well-established principles of chemical risk assessment. In this commentary, endocrine disrupter experts express their concerns about a recently published, and is in our considered opinion inaccurate and factually incorrect, editorial that has appeared in several journals in toxicology. Some of the shortcomings of the editorial are discussed in detail. We call for a better founded scientific debate which may help to overcome a polarisation of views detrimental to reaching a consensus about scientific foundations for endocrine disrupter regulation in the EU.
Hormones And Endocrine-Disrupting Chemicals: Low-Dose Effects And Nonmonotonic Dose Responses, Laura Vandenberg, Theo Colborn, Tyrone Hayes, Jerrold Heindel, David Jacobs Jr., Duk-Hee Lee, Toshi Shioda, Ana Soto, Frederick Vom Saal, Wade Welshons, R. Zoeller, John Myers
Hormones And Endocrine-Disrupting Chemicals: Low-Dose Effects And Nonmonotonic Dose Responses, Laura Vandenberg, Theo Colborn, Tyrone Hayes, Jerrold Heindel, David Jacobs Jr., Duk-Hee Lee, Toshi Shioda, Ana Soto, Frederick Vom Saal, Wade Welshons, R. Zoeller, John Myers
Laura Vandenberg
For decades, studies of endocrine-disrupting chemicals (EDCs) have challenged traditional concepts in toxicology, in particular the dogma of “the dose makes the poison,” because EDCs can have effects at low doses that are not predicted by effects at higher doses. Here, we review two major concepts in EDC studies: low dose and nonmonotonicity. Low-dose effects were defined by the National Toxicology Program as those that occur in the range of human exposures or effects observed at doses below those used for traditional toxicological studies. We review the mechanistic data for low-dose effects and use a weight-of-evidence approach to analyze five …
Exposure To Bisphenol A In Canada: Invoking The Precautionary Principle, Laura Vandenberg
Exposure To Bisphenol A In Canada: Invoking The Precautionary Principle, Laura Vandenberg
Laura Vandenberg
No abstract provided.
Biomonitoring Studies Should Be Used By Regulatory Agencies To Assess Human Exposure Levels And Safety Of Bisphenol A, Laura Vandenberg, Ibrahim Chahoud, Vasantha Padmanabhan, Francisco Paumgartten, Gilbert Schoenfelder
Biomonitoring Studies Should Be Used By Regulatory Agencies To Assess Human Exposure Levels And Safety Of Bisphenol A, Laura Vandenberg, Ibrahim Chahoud, Vasantha Padmanabhan, Francisco Paumgartten, Gilbert Schoenfelder
Laura Vandenberg
BACKGROUND: Within the past 3 years, four major evaluations of bisphenol A (BPA) safety have been undertaken. However, these assessments have arrived at quite different conclusions regarding the safety of BPA at current human exposure levels. OBJECTIVES: We compared the reasons provided by the European Food Safety Authority (EFSA) BPA risk assessment panel for their conclusion that human exposures are negligible with the conclusions reached by the other panels, with all panels having the same body of literature at their disposal. DISCUSSION: The EFSA panel dismissed > or = 80 biomonitoring studies that documented significant levels of BPA exposure in humans, …
Urinary, Circulating, And Tissue Biomonitoring Studies Indicate Widespread Exposure To Bisphenol A, Laura Vandenberg, Ibrahim Chahoud, Jerrold J. Heindel, Vasantha Padmanabhan, Francisco J.R. Paumgartten, Gilbert Schoenfelder
Urinary, Circulating, And Tissue Biomonitoring Studies Indicate Widespread Exposure To Bisphenol A, Laura Vandenberg, Ibrahim Chahoud, Jerrold J. Heindel, Vasantha Padmanabhan, Francisco J.R. Paumgartten, Gilbert Schoenfelder
Laura Vandenberg
BACKGROUND: Bisphenol A (BPA) is one of the highest-volume chemicals produced worldwide, and human exposure to BPA is thought to be ubiquitous. Thus, there are concerns that the amount of BPA to which humans are exposed may cause adverse health effects. Importantly, results from a large number of biomonitoring studies are at odds with the results from two toxicokinetic studies. OBJECTIVE: We examined several possibilities for why biomonitoring and toxicokinetic studies could come to seemingly conflicting conclusions. DATA SOURCES: We examined > 80 published human biomonitoring studies that measured BPA concentrations in human tissues, urine, blood, and other fluids, along with …
Bisphenol-A And The Great Divide: A Review Of Controversies In The Field Of Endocrine Disruption, Laura Vandenberg, Maricel V. Maffini, Carlos Sonnenschein, Beverly S. Rubin, Ana M. Soto
Bisphenol-A And The Great Divide: A Review Of Controversies In The Field Of Endocrine Disruption, Laura Vandenberg, Maricel V. Maffini, Carlos Sonnenschein, Beverly S. Rubin, Ana M. Soto
Laura Vandenberg
In 1991, a group of 21 scientists gathered at the Wingspread Conference Center to discuss evidence of developmental alterations observed in wildlife populations after chemical exposures. There, the term “endocrine disruptor” was agreed upon to describe a class of chemicals including those that act as agonists and antagonists of the estrogen receptors (ERs), androgen receptor, thyroid hormone receptor, and others. This definition has since evolved, and the field has grown to encompass hundreds of chemicals. Despite significant advances in the study of endocrine disruptors, several controversies have sprung up and continue, including the debate over the existence of nonmonotonic dose …
Why Public Health Agencies Cannot Depend On Good Laboratory Practices As A Criterion For Selecting Data: The Case Of Bisphenol A, John Peterson Myers, Frederick S. Vom Saal, Benson T. Akingbemi, Koji Arizono, Scott Belcher, Theo Colborn, Ibrahim Chahoud, D. Andrew Crain, Francesca Farabollini, Louis J. Guillette Jr., Terry Hassold, Shuk-Mei Ho, Patricia A. Hunt, Taisen Iguchi, Susan Jobling, Jun Kanno, Hans Laufer, Michele Marcus, John A. Mclachlan, Angel Nadal, Jörg Oehlmann, Nicolás Olea, Paola Palanza, Stefano Parmigiani, Beverly S. Rubin, Gilbert Schoenfelder, Carlos Sonnenschein, Ana M. Soto, Chris E. Talsness, Julia A. Taylor, Laura Vandenberg, John G. Vandenbergh, Sarah Vogel, Cheryl S. Watson, Wade V. Welshons, R. Thomas Zoeller
Why Public Health Agencies Cannot Depend On Good Laboratory Practices As A Criterion For Selecting Data: The Case Of Bisphenol A, John Peterson Myers, Frederick S. Vom Saal, Benson T. Akingbemi, Koji Arizono, Scott Belcher, Theo Colborn, Ibrahim Chahoud, D. Andrew Crain, Francesca Farabollini, Louis J. Guillette Jr., Terry Hassold, Shuk-Mei Ho, Patricia A. Hunt, Taisen Iguchi, Susan Jobling, Jun Kanno, Hans Laufer, Michele Marcus, John A. Mclachlan, Angel Nadal, Jörg Oehlmann, Nicolás Olea, Paola Palanza, Stefano Parmigiani, Beverly S. Rubin, Gilbert Schoenfelder, Carlos Sonnenschein, Ana M. Soto, Chris E. Talsness, Julia A. Taylor, Laura Vandenberg, John G. Vandenbergh, Sarah Vogel, Cheryl S. Watson, Wade V. Welshons, R. Thomas Zoeller
Laura Vandenberg
BACKGROUND: In their safety evaluations of bisphenol A (BPA), the U.S. Food and Drug Administration (FDA) and a counterpart in Europe, the European Food Safety Authority (EFSA), have given special prominence to two industry-funded studies that adhered to standards defined by Good Laboratory Practices (GLP). These same agencies have given much less weight in risk assessments to a large number of independently replicated non-GLP studies conducted with government funding by the leading experts in various fields of science from around the world. OBJECTIVES: We reviewed differences between industry-funded GLP studies of BPA conducted by commercial laboratories for regulatory purposes and …